FTC to appeal Shire ViroPharma ‘abuse’ decision

12-04-2018

FTC to appeal Shire ViroPharma ‘abuse’ decision

Warchi /iStockphoto.com

The US Federal Trade Commission (FTC) is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire.


Shire, Shire Viropharma, FTC, anti-competition, antitrust, FDA, ANDA, Vancocin, generics, generic competition

LSIPR